1. Home
  2. SACH vs VNRX Comparison

SACH vs VNRX Comparison

Compare SACH & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sachem Capital Corp.

SACH

Sachem Capital Corp.

N/A

Current Price

$1.09

Market Cap

48.6M

Sector

Real Estate

ML Signal

N/A

Logo VolitionRX Limited

VNRX

VolitionRX Limited

N/A

Current Price

$0.20

Market Cap

31.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SACH
VNRX
Founded
2010
N/A
Country
United States
United States
Employees
29
N/A
Industry
Real Estate Investment Trusts
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
48.6M
31.9M
IPO Year
N/A
2012

Fundamental Metrics

Financial Performance
Metric
SACH
VNRX
Price
$1.09
$0.20
Analyst Decision
Hold
Strong Buy
Analyst Count
3
4
Target Price
$2.00
$2.50
AVG Volume (30 Days)
122.6K
1.6M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
18.18%
N/A
EPS Growth
N/A
38.00
EPS
N/A
N/A
Revenue
N/A
$1,233,511.00
Revenue This Year
N/A
$68.22
Revenue Next Year
$1.17
$382.75
P/E Ratio
N/A
N/A
Revenue Growth
N/A
59.10
52 Week Low
$0.80
$0.17
52 Week High
$1.35
$0.94

Technical Indicators

Market Signals
Indicator
SACH
VNRX
Relative Strength Index (RSI) 61.00 40.64
Support Level $1.04 $0.17
Resistance Level $1.12 $0.27
Average True Range (ATR) 0.03 0.02
MACD 0.01 0.00
Stochastic Oscillator 67.80 30.98

Price Performance

Historical Comparison
SACH
VNRX

About SACH Sachem Capital Corp.

Sachem Capital Corp is a real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. The company earns majority of its revenue through Interest income from loans.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Share on Social Networks: